| Global incidence, prevalence, years lived with disability (YLDs), disability-adjusted life-years (DALYs), and healthy life expectancy (HALE) for 371 diseases and injuries in … AJ Ferrari, DF Santomauro, A Aali, YH Abate, C Abbafati, H Abbastabar, ... The Lancet 403 (10440), 2133-2161, 2024 | 552 | 2024 |
| Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990–2021: a systematic analysis for the … M Naghavi, KL Ong, A Aali, HS Ababneh, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2100-2132, 2024 | 517 | 2024 |
| Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the Global Burden of Disease … M Brauer, GA Roth, AY Aravkin, P Zheng, KH Abate, YH Abate, C Abbafati, ... The Lancet 403 (10440), 2162-2203, 2024 | 514 | 2024 |
| Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: a systematic analysis for the Global Burden of Disease Study 2021 JD Steinmetz, KM Seeher, N Schiess, E Nichols, B Cao, C Servili, ... The Lancet Neurology 23 (4), 344-381, 2024 | 484 | 2024 |
| Mobile health apps on COVID-19 launched in the early days of the pandemic: content analysis and review LC Ming, N Untong, NA Aliudin, N Osili, N Kifli, CS Tan, KW Goh, PW Ng, ... JMIR mHealth and uHealth 8 (9), e19796, 2020 | 421 | 2020 |
| A Guide to Online Pharmacy Education: Teaching Strategies and Assessment Methods Y Al-Worafi CRC Press, 2022 | 325 | 2022 |
| Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950–2021, and the impact of the … AE Schumacher, HH Kyu, A Aali, C Abbafati, J Abbas, ... The Lancet 403 (10440), 1989-2056, 2024 | 319 | 2024 |
| Drug safety in developing countries: Achievements and challenges YM Al-Worafi Academic Press, 2020 | 294 | 2020 |
| Outbreak of vaccine-preventable diseases in Muslim majority countries A Ahmed, KS Lee, A Bukhsh, YM Al-Worafi, MMR Sarker, LC Ming, ... Journal of infection and public health 11 (2), 153-155, 2018 | 293 | 2018 |
| Self-Medication Among King Khalid University Students, Saudi Arabia SM Alshahrani, SS Alavudeen, KM Alakhali, YM Al-Worafi, AK Bahamdan, ... Risk Management and Healthcare Policy 12, 243–249, 2019 | 267 | 2019 |
| Combating sale of counterfeit and falsified medicines online: A losing battle KS Lee, SM Yee, STR Zaidi, RP Patel, Q Yang, YM Al-Worafi, LC Ming Frontiers in pharmacology 8, 268, 2017 | 256 | 2017 |
| Pharmacy practice and its challenges in Yemen YM Al-Worafi Australas Med J 7 (1), 17-23, 2014 | 256 | 2014 |
| Perception of self‑medication among university students in Saudi Arabia MS Saeed, AS Alkhoshaiban, YMA Al‑Worafi, CM Long Archives of Pharmacy Practice 5 (4-2014), 149-152, 2014 | 250 | 2014 |
| Patient safety in developing countries: Education, research, case studies Y Al-Worafi CRC Press, 2023 | 239 | 2023 |
| Clinical Case Studies on Medication Safety YM Al-Worafi Academic Press, 2023 | 234 | 2023 |
| Medication errors YM Al-Worafi Drug safety in developing countries, 59-71, 2020 | 232 | 2020 |
| Self-medication YM Al-Worafi Drug safety in developing countries, 73-86, 2020 | 231 | 2020 |
| Burden of disease scenarios for 204 countries and territories, 2022–2050: a forecasting analysis for the Global Burden of Disease Study 2021 SE Vollset, HS Ababneh, YH Abate, C Abbafati, R Abbasgholizadeh, ... The Lancet 403 (10440), 2204-2256, 2024 | 225 | 2024 |
| Herbal medicines safety issues YM Al-Worafi Drug safety in developing countries, 163-178, 2020 | 219 | 2020 |
| Pharmacovigilance and adverse drug reaction reporting: A perspective of community pharmacists and pharmacy technicians in Sana’a, Yemen YM Al-Worafi, YW Kassab, WM Alseragi, MS Almutairi, A Ahmed, LC Ming, ... Therapeutics and clinical risk management, 1175-1181, 2017 | 219 | 2017 |
